# Trial of Oral Hyaluronic Acid for the Prevention of Aromatase Inhibitor-Associated Arthralgias

> **NCT03384095** · PHASE2 · WITHDRAWN · sponsor: **Erin Newton**

## Conditions studied

- Breast Neoplasm Female
- Arthralgia

## Interventions

- **DRUG:** Hyaluronic Acid (HA)
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03384095
- **Lead sponsor:** Erin Newton
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-12-14
- **Primary completion:** 2018-12-14
- **Final completion:** 2018-12-14
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** study abandoned prior to opening to accrual or study start
- **Last updated:** 2019-01-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03384095

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03384095, "Trial of Oral Hyaluronic Acid for the Prevention of Aromatase Inhibitor-Associated Arthralgias". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03384095. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*